Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease

We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 1...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 51; pp. 132 - 140
Main Authors Kreisl, William C., Lyoo, Chul Hyoung, Liow, Jeih-San, Snow, Joseph, Page, Emily, Jenko, Kimberly J., Morse, Cheryl L., Zoghbi, Sami S., Pike, Victor W., Turner, R. Scott, Innis, Robert B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater 11C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11C-PBR28 binding in inferior and medial temporal cortex. Increased 11C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
AbstractList We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater C-PBR28 binding in inferior and medial temporal cortex. Increased C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
Abstract We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with11 C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater11 C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater11 C-PBR28 binding in inferior and medial temporal cortex. Increased11 C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa (TSPO), a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer’s disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11 C-PBR28 to measure TSPO. PCA patients showed greater 11 C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11 C-PBR28 binding in inferior and medial temporal cortex. Increased 11 C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater 11C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11C-PBR28 binding in inferior and medial temporal cortex. Increased 11C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater 11C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11C-PBR28 binding in inferior and medial temporal cortex. Increased 11C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater 11C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11C-PBR28 binding in inferior and medial temporal cortex. Increased 11C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD.
Author Zoghbi, Sami S.
Kreisl, William C.
Turner, R. Scott
Morse, Cheryl L.
Liow, Jeih-San
Jenko, Kimberly J.
Innis, Robert B.
Lyoo, Chul Hyoung
Page, Emily
Pike, Victor W.
Snow, Joseph
AuthorAffiliation b Office of the Clinical Director, National Institute of Mental Health, Bethesda, MD
a Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD
c Memory Disorders Program, Georgetown University, Washington, DC
AuthorAffiliation_xml – name: a Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD
– name: b Office of the Clinical Director, National Institute of Mental Health, Bethesda, MD
– name: c Memory Disorders Program, Georgetown University, Washington, DC
Author_xml – sequence: 1
  givenname: William C.
  surname: Kreisl
  fullname: Kreisl, William C.
  email: wck2107@cumc.columbia.edu
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 2
  givenname: Chul Hyoung
  surname: Lyoo
  fullname: Lyoo, Chul Hyoung
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 3
  givenname: Jeih-San
  surname: Liow
  fullname: Liow, Jeih-San
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 4
  givenname: Joseph
  surname: Snow
  fullname: Snow, Joseph
  organization: Office of the Clinical Director, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 5
  givenname: Emily
  surname: Page
  fullname: Page, Emily
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 6
  givenname: Kimberly J.
  surname: Jenko
  fullname: Jenko, Kimberly J.
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 7
  givenname: Cheryl L.
  surname: Morse
  fullname: Morse, Cheryl L.
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 8
  givenname: Sami S.
  surname: Zoghbi
  fullname: Zoghbi, Sami S.
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 9
  givenname: Victor W.
  surname: Pike
  fullname: Pike, Victor W.
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
– sequence: 10
  givenname: R. Scott
  surname: Turner
  fullname: Turner, R. Scott
  organization: Memory Disorders Program, Georgetown University, Washington, DC, USA
– sequence: 11
  givenname: Robert B.
  surname: Innis
  fullname: Innis, Robert B.
  organization: Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28068564$$D View this record in MEDLINE/PubMed
BookMark eNqNkt9rFDEQx4NU7LX6L0geBH25Nckm2SxIoT9sFQo-qM8hl529y7mXrEmucP71ZrlW2oJwT4GZ73wmM985QUc-eEDoHSUVJVR-XFcetjEsXBjM0vllxUq0oqwiRL5AMyqEmlPeNkdoRmjbzLlQ5BidpLQmhDS8ka_QMVNEKiH5DMUrl7LzNuPR5AzRJxx6XAIRTIIO52h8GoI1OUQ8xpDB-ZLGY0hF7UrQhpidNQM2OYZxtcPGd9hsPBSuxefDnxW4DcT3CXcuTdDX6GVvhgRv7t9T9PP684_LL_PbbzdfL89v51a0TM6ZMVaK3jDS0MZSwXthF7XkiouF4aRRbZmsaWvedjUVzDBmZV93CyW5oKbn9Sk623PH7WIDnQVfhhn0GN3GxJ0OxumnGe9WehnutKgVFbQtgA_3gBh-b8s8euOShWEwHsI2aapEUzdKCFGkbx_3-tfkYdFFcLEX2BhSitBr67LJLkyt3aAp0ZO7eq2fuqsndzVlurhbIJ-eQR76HFh-vS-HsvU7B1En68Bb6FwEm3UX3KGgs2cgOzg_HcEv2EFah230xVlNdSoF-vt0h9MZUlmTmjJVAFf_Bxz-j79mBfql
CitedBy_id crossref_primary_10_1186_s13195_020_00619_0
crossref_primary_10_1111_ejn_15613
crossref_primary_10_2174_0929867329666220329204054
crossref_primary_10_1016_j_apsb_2020_08_006
crossref_primary_10_1111_psyg_12665
crossref_primary_10_1016_j_jalz_2019_02_004
crossref_primary_10_1080_19420862_2018_1473910
crossref_primary_10_1186_s42234_021_00065_9
crossref_primary_10_1016_j_dadm_2019_02_004
crossref_primary_10_1016_j_neurol_2022_12_006
crossref_primary_10_1007_s00702_017_1731_x
crossref_primary_10_3389_fneur_2018_00625
crossref_primary_10_1093_brain_awy188
crossref_primary_10_1002_acn3_50837
crossref_primary_10_1016_S1474_4422_20_30346_X
crossref_primary_10_1093_brain_awz136
crossref_primary_10_1093_braincomms_fcaa024
crossref_primary_10_3389_fneur_2019_00670
crossref_primary_10_3390_ijms18050993
crossref_primary_10_1097_MD_0000000000038086
crossref_primary_10_3389_fneur_2023_1189278
crossref_primary_10_1016_S1474_4422_20_30440_3
crossref_primary_10_1002_acn3_50802
crossref_primary_10_1007_s11307_017_1129_z
crossref_primary_10_3389_fnagi_2021_624330
crossref_primary_10_1053_j_semnuclmed_2020_12_008
crossref_primary_10_1016_j_cpet_2017_03_001
crossref_primary_10_1016_j_neurobiolaging_2019_09_019
crossref_primary_10_1177_0271678X18771250
crossref_primary_10_1111_nan_13009
crossref_primary_10_1002_mds_28825
crossref_primary_10_1016_j_trac_2024_117546
crossref_primary_10_1016_j_nrl_2023_03_006
crossref_primary_10_1093_brain_awy079
crossref_primary_10_1002_alz_13699
crossref_primary_10_3389_fneur_2017_00389
crossref_primary_10_1016_j_arr_2019_01_002
crossref_primary_10_1002_alz_12120
Cites_doi 10.1016/j.neuroimage.2007.11.011
10.1007/s00259-011-1745-9
10.1136/jnnp.74.11.1521
10.1016/j.jalz.2011.03.005
10.1212/WNL.0b013e31821cccad
10.1093/brain/aws327
10.1111/j.1365-2990.2008.01006.x
10.1093/brain/awv288
10.1038/jcbfm.2012.131
10.1093/brain/awt145
10.1371/journal.pone.0134956
10.1093/brain/awr130
10.2967/jnumed.114.146027
10.1136/jnnp-2013-305628
10.1038/sj.jcbfm.9600146
10.1212/01.WNL.0000140289.18472.15
10.1093/brain/aww027
10.3233/JAD-131843
10.1093/brain/awm336
10.3233/JAD-2008-15301
10.1159/000314679
10.1212/WNL.0b013e31821103e6
10.1007/s00401-013-1177-7
10.1016/j.jalz.2011.03.008
10.1523/JNEUROSCI.4361-12.2013
10.1212/01.wnl.0000228230.26044.a4
10.1016/j.neurobiolaging.2016.04.011
10.1001/archneur.64.8.1140
10.1038/jcbfm.2011.147
10.1016/j.nbd.2008.08.001
ContentType Journal Article
Copyright 2016
Published by Elsevier Inc.
Copyright_xml – notice: 2016
– notice: Published by Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.neurobiolaging.2016.12.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE



MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1558-1497
EndPage 140
ExternalDocumentID PMC5381519
28068564
10_1016_j_neurobiolaging_2016_12_006
S0197458016303128
1_s2_0_S0197458016303128
Genre Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Intramural NIH HHS
  grantid: ZIA MH002852
– fundername: Intramural NIH HHS
  grantid: Z01 MH002793
– fundername: Intramural NIH HHS
  grantid: Z01 MH002852
GroupedDBID ---
--K
--M
-~X
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABGSF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOYX
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M2V
M41
MO0
MOBAO
MVM
N9A
O-L
O9-
OAUVE
OD~
OKEIE
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SSB
SSH
SSN
SSU
SSY
SSZ
T5K
WUQ
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AFYLN
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c5926-2aac65fa20717c154f5cb364845ba4078945879349d3152a22c6f3db86451af43
IEDL.DBID .~1
ISSN 0197-4580
1558-1497
IngestDate Thu Aug 21 13:35:33 EDT 2025
Mon Jul 21 09:44:40 EDT 2025
Mon Jul 21 06:02:31 EDT 2025
Thu Apr 24 22:57:25 EDT 2025
Tue Jul 01 01:28:18 EDT 2025
Fri Feb 23 02:19:56 EST 2024
Tue Feb 25 20:11:14 EST 2025
Tue Aug 26 16:35:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords PET imaging
Neuroinflammation
Alzheimer's disease
Language English
License Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5926-2aac65fa20717c154f5cb364845ba4078945879349d3152a22c6f3db86451af43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
Taub Institute, Columbia University Medical Center, New York, NY
OpenAccessLink http://doi.org/10.1016/j.neurobiolaging.2016.12.006
PMID 28068564
PQID 1857378555
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5381519
proquest_miscellaneous_1857378555
pubmed_primary_28068564
crossref_citationtrail_10_1016_j_neurobiolaging_2016_12_006
crossref_primary_10_1016_j_neurobiolaging_2016_12_006
elsevier_sciencedirect_doi_10_1016_j_neurobiolaging_2016_12_006
elsevier_clinicalkeyesjournals_1_s2_0_S0197458016303128
elsevier_clinicalkey_doi_10_1016_j_neurobiolaging_2016_12_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-03-01
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurobiology of aging
PublicationTitleAlternate Neurobiol Aging
PublicationYear 2017
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Formaglio, Costes, Seguin, Tholance, Le Bars, Roullet-Solignac, Mercier, Krolak-Salmon, Vighetto (bib7) 2011; 258
Lopresti, Klunk, Mathis, Hoge, Ziolko, Lu, Meltzer, Schimmel, Tsopelas, DeKosky, Price (bib17) 2005; 46
Gorno-Tempini, Hillis, Weintraub, Kertesz, Mendez, Cappa, Ogar, Rohrer, Black, Boeve, Manes, Dronkers, Vandenberghe, Rascovsky, Patterson, Miller, Knopman, Hodges, Mesulam, Grossman (bib10) 2011; 76
Rosenbloom, Alkalay, Agarwal, Baker, O'Neil, Janabi, Yen, Growdon, Jang, Madison, Mormino, Rosen, Gorno-Tempini, Weiner, Miller, Jagust, Rabinovici (bib28) 2011; 76
Schmidtke, Hull, Talazko (bib29) 2005; 252
Wang, Lu, Shi, Cai, Liu, Liu, Han, Wang, Zhou, Wang, Gao, Ji (bib34) 2015; 10
Cosenza-Nashat, Zhao, Suh, Morgan, Natividad, Morgello, Lee (bib3) 2009; 35
Fujita, Imaizumi, Zoghbi, Fujimura, Farris, Suhara, Hong, Pike, Innis (bib8) 2008; 40
Kreisl, Lyoo, McGwier, Snow, Jenko, Kimura, Corona, Morse, Zoghbi, Pike, McMahon, Turner, Innis (bib15) 2013; 136
McGeer, McGeer (bib19) 2013; 126
Mintun, LaRossa, Sheline, Dence, Lee, Mach, Klunk, Mathis, DeKosky, Morris (bib21) 2006; 67
Fan, Okello, Brooks, Edison (bib6) 2015; 138
Ghosh, Wu, Shaftel, Kyrkanides, LaFerla, Olschowka, O'Banion (bib9) 2013; 33
Kreisl, Jenko, Hines, Lyoo, Corona, Morse, Zoghbi, Hyde, Kleinman, Pike, McMahon, Innis (bib13) 2013; 33
Ng, Villemagne, Masters, Rowe (bib24) 2007; 64
Tenovuo, Kemppainen, Aalto, Nagren, Rinne (bib32) 2008; 15
Lehmann, Ghosh, Madison, Laforce, Corbetta-Rastelli, Weiner, Greicius, Seeley, Gorno-Tempini, Rosen, Miller, Jagust, Rabinovici (bib16) 2013; 136
Singh, Josephs, Machulda, Drubach, Apostolova, Lowe, Whitwell (bib30) 2015; 262
McKhann, Knopman, Chertkow, Hyman, Jack, Kawas, Klunk, Koroshetz, Manly, Mayeux, Mohs, Morris, Rossor, Scheltens, Carrillo, Thies, Weintraub, Phelps (bib20) 2011; 7
Morales, Jimenez, Mancilla, Maccioni (bib22) 2013; 37
Price, Klunk, Lopresti, Lu, Hoge, Ziolko, Holt, Meltzer, DeKosky, Mathis (bib27) 2005; 25
Ossenkoppele, Schonhaut, Schöll, Lockhart, Ayakta, Baker, O'Neil, Janabi, Lazaris, Cantwell, Vogel, Santos, Miller, Bettcher, Vossel, Kramer, Gorno-Tempini, Miller, Jagust, Rabinovici (bib25) 2016; 139
Lyoo, Ikawa, Liow, Zoghbi, Morse, Pike, Fujita, Innis, Kreisl (bib18) 2015; 56
Kreisl, Lyoo, Liow, Wei, Snow, Page, Jenko, Morse, Zoghbi, Pike, Turner, Innis (bib14) 2016; 44
Tang-Wai, Graff-Radford, Boeve, Dickson, Parisi, Crook, Caselli, Knopman, Petersen (bib31) 2004; 63
Owen, Yeo, Gunn, Song, Wadsworth, Lewis, Rhodes, Pulford, Bennacef, Parker, StJean, Cardon, Mooser, Matthews, Rabiner, Rubio (bib26) 2012; 32
Whitwell, Lowe, Duffy, Strand, Machulda, Kantarci, Wille, Senjem, Murphy, Gunter, Jack, Josephs (bib35) 2013; 84
Edison, Archer, Gerhard, Hinz, Pavese, Turkheimer, Hammers, Tai, Fox, Kennedy, Rossor, Brooks (bib5) 2008; 32
de Souza, Corlier, Habert, Uspenskaya, Maroy, Lamari, Chupin, Lehéricy, Colliot, Hahn-Barma, Samri, Dubois, Bottlaender, Sarazin (bib4) 2011; 134
Nestor, Caine, Fryer, Clarke, Hodges (bib23) 2003; 74
Jack, Lowe, Senjem, Weigand, Kemp, Shiung, Knopman, Boeve, Klunk, Mathis, Petersen (bib11) 2008; 131
Kambe, Motoi, Ishii, Hattori (bib12) 2010; 257
Thomas, Erlandsson, Modat, Thurfjell, Vandenberghe, Ourselin, Hutton (bib33) 2011; 38
Baumann, Duyar, Sollberger, Kuhle, Regeniter, Gomez-Mancilla, Schmidtke, Monsch (bib2) 2010; 29
Albert, DeKosky, Dickson, Dubois, Feldman, Fox, Gamst, Holtzman, Jagust, Petersen, Snyder, Carrillo, Thies, Phelps (bib1) 2011; 7
Ghosh (10.1016/j.neurobiolaging.2016.12.006_bib9) 2013; 33
Edison (10.1016/j.neurobiolaging.2016.12.006_bib5) 2008; 32
Owen (10.1016/j.neurobiolaging.2016.12.006_bib26) 2012; 32
Jack (10.1016/j.neurobiolaging.2016.12.006_bib11) 2008; 131
Morales (10.1016/j.neurobiolaging.2016.12.006_bib22) 2013; 37
Singh (10.1016/j.neurobiolaging.2016.12.006_bib30) 2015; 262
Gorno-Tempini (10.1016/j.neurobiolaging.2016.12.006_bib10) 2011; 76
Cosenza-Nashat (10.1016/j.neurobiolaging.2016.12.006_bib3) 2009; 35
Fan (10.1016/j.neurobiolaging.2016.12.006_bib6) 2015; 138
Kreisl (10.1016/j.neurobiolaging.2016.12.006_bib14) 2016; 44
Wang (10.1016/j.neurobiolaging.2016.12.006_bib34) 2015; 10
Albert (10.1016/j.neurobiolaging.2016.12.006_bib1) 2011; 7
Whitwell (10.1016/j.neurobiolaging.2016.12.006_bib35) 2013; 84
Schmidtke (10.1016/j.neurobiolaging.2016.12.006_bib29) 2005; 252
Thomas (10.1016/j.neurobiolaging.2016.12.006_bib33) 2011; 38
Kreisl (10.1016/j.neurobiolaging.2016.12.006_bib13) 2013; 33
Baumann (10.1016/j.neurobiolaging.2016.12.006_bib2) 2010; 29
de Souza (10.1016/j.neurobiolaging.2016.12.006_bib4) 2011; 134
Kreisl (10.1016/j.neurobiolaging.2016.12.006_bib15) 2013; 136
Kambe (10.1016/j.neurobiolaging.2016.12.006_bib12) 2010; 257
Fujita (10.1016/j.neurobiolaging.2016.12.006_bib8) 2008; 40
Lopresti (10.1016/j.neurobiolaging.2016.12.006_bib17) 2005; 46
McGeer (10.1016/j.neurobiolaging.2016.12.006_bib19) 2013; 126
Formaglio (10.1016/j.neurobiolaging.2016.12.006_bib7) 2011; 258
McKhann (10.1016/j.neurobiolaging.2016.12.006_bib20) 2011; 7
Lyoo (10.1016/j.neurobiolaging.2016.12.006_bib18) 2015; 56
Ng (10.1016/j.neurobiolaging.2016.12.006_bib24) 2007; 64
Mintun (10.1016/j.neurobiolaging.2016.12.006_bib21) 2006; 67
Nestor (10.1016/j.neurobiolaging.2016.12.006_bib23) 2003; 74
Tang-Wai (10.1016/j.neurobiolaging.2016.12.006_bib31) 2004; 63
Ossenkoppele (10.1016/j.neurobiolaging.2016.12.006_bib25) 2016; 139
Tenovuo (10.1016/j.neurobiolaging.2016.12.006_bib32) 2008; 15
Rosenbloom (10.1016/j.neurobiolaging.2016.12.006_bib28) 2011; 76
Price (10.1016/j.neurobiolaging.2016.12.006_bib27) 2005; 25
Lehmann (10.1016/j.neurobiolaging.2016.12.006_bib16) 2013; 136
References_xml – volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  ident: bib1
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 136
  start-page: 2228
  year: 2013
  end-page: 2238
  ident: bib15
  article-title: In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease
  publication-title: Brain
– volume: 136
  start-page: 844
  year: 2013
  end-page: 858
  ident: bib16
  article-title: Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
  publication-title: Brain
– volume: 25
  start-page: 1528
  year: 2005
  end-page: 1547
  ident: bib27
  article-title: Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 38
  start-page: 1104
  year: 2011
  end-page: 1119
  ident: bib33
  article-title: The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
  publication-title: Eu. J. Nucl. Med. Mol. Imaging
– volume: 258
  start-page: 1841
  year: 2011
  end-page: 1851
  ident: bib7
  article-title: In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings
  publication-title: J. Neurol.
– volume: 40
  start-page: 43
  year: 2008
  end-page: 52
  ident: bib8
  article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation
  publication-title: NeuroImage
– volume: 46
  start-page: 1959
  year: 2005
  end-page: 1972
  ident: bib17
  article-title: Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis
  publication-title: J. Nucl. Med.
– volume: 63
  start-page: 1168
  year: 2004
  end-page: 1174
  ident: bib31
  article-title: Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
  publication-title: Neurology
– volume: 139
  start-page: 1551
  year: 2016
  end-page: 1567
  ident: bib25
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
  publication-title: Brain
– volume: 33
  start-page: 5053
  year: 2013
  end-page: 5064
  ident: bib9
  article-title: Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model
  publication-title: J. Neurosci.
– volume: 257
  start-page: 469
  year: 2010
  end-page: 471
  ident: bib12
  article-title: Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex
  publication-title: J. Neurol.
– volume: 56
  start-page: 701
  year: 2015
  end-page: 706
  ident: bib18
  article-title: Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein
  publication-title: J. Nucl. Med.
– volume: 33
  start-page: 53
  year: 2013
  end-page: 58
  ident: bib13
  article-title: A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 10
  start-page: e0134956
  year: 2015
  ident: bib34
  article-title: A pilot study on clinical and neuroimaging characteristics of Chinese posterior cortical atrophy: comparison with typical Alzheimer's disease
  publication-title: PLoS One
– volume: 76
  start-page: 1006
  year: 2011
  end-page: 1014
  ident: bib10
  article-title: Classification of primary progressive aphasia and its variants
  publication-title: Neurology
– volume: 37
  start-page: 849
  year: 2013
  end-page: 856
  ident: bib22
  article-title: Tau oligomers and fibrils induce activation of microglial cells
  publication-title: J. Alzheimers Dis.
– volume: 134
  start-page: 2036
  year: 2011
  end-page: 2043
  ident: bib4
  article-title: Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease
  publication-title: Brain
– volume: 32
  start-page: 1
  year: 2012
  end-page: 5
  ident: bib26
  article-title: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 29
  start-page: 530
  year: 2010
  end-page: 533
  ident: bib2
  article-title: CSF-tau and CSF-Abeta(1-42) in posterior cortical atrophy
  publication-title: Dement Geriatr. Cogn. Disord.
– volume: 76
  start-page: 1789
  year: 2011
  end-page: 1796
  ident: bib28
  article-title: Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
  publication-title: Neurology
– volume: 35
  start-page: 306
  year: 2009
  end-page: 328
  ident: bib3
  article-title: Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
  publication-title: Neuropathol. Appl. Neurobiol.
– volume: 32
  start-page: 412
  year: 2008
  end-page: 419
  ident: bib5
  article-title: Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study
  publication-title: Neurobiol. Dis.
– volume: 7
  start-page: 263
  year: 2011
  end-page: 269
  ident: bib20
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 126
  start-page: 479
  year: 2013
  end-page: 497
  ident: bib19
  article-title: The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
  publication-title: Acta Neuropathol.
– volume: 74
  start-page: 1521
  year: 2003
  end-page: 1529
  ident: bib23
  article-title: The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET
  publication-title: J. Neurol. Neurosurg. Psychiatry
– volume: 67
  start-page: 446
  year: 2006
  end-page: 452
  ident: bib21
  article-title: [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease
  publication-title: Neurology
– volume: 64
  start-page: 1140
  year: 2007
  end-page: 1144
  ident: bib24
  article-title: Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B
  publication-title: Arch. Neurol.
– volume: 252
  start-page: 27
  year: 2005
  end-page: 35
  ident: bib29
  article-title: Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings
  publication-title: J. Neurol.
– volume: 138
  start-page: 3685
  year: 2015
  end-page: 3698
  ident: bib6
  article-title: Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease
  publication-title: Brain
– volume: 131
  start-page: 665
  year: 2008
  end-page: 680
  ident: bib11
  article-title: 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
  publication-title: Brain
– volume: 262
  start-page: 1483
  year: 2015
  end-page: 1492
  ident: bib30
  article-title: Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
  publication-title: J. Neurol.
– volume: 44
  start-page: 53
  year: 2016
  end-page: 61
  ident: bib14
  article-title: 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
  publication-title: Neurobiol. Aging
– volume: 15
  start-page: 351
  year: 2008
  end-page: 355
  ident: bib32
  article-title: Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation
  publication-title: J. Alzheimers Dis.
– volume: 84
  start-page: 1357
  year: 2013
  end-page: 1364
  ident: bib35
  article-title: Elevated occipital beta-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia
  publication-title: J. Neurol. Neurosurg. Psychiatry
– volume: 40
  start-page: 43
  year: 2008
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib8
  article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2007.11.011
– volume: 38
  start-page: 1104
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib33
  article-title: The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
  publication-title: Eu. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-011-1745-9
– volume: 74
  start-page: 1521
  year: 2003
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib23
  article-title: The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp.74.11.1521
– volume: 7
  start-page: 263
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib20
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2011.03.005
– volume: 76
  start-page: 1789
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib28
  article-title: Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821cccad
– volume: 136
  start-page: 844
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib16
  article-title: Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/aws327
– volume: 35
  start-page: 306
  year: 2009
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib3
  article-title: Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
  publication-title: Neuropathol. Appl. Neurobiol.
  doi: 10.1111/j.1365-2990.2008.01006.x
– volume: 138
  start-page: 3685
  year: 2015
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib6
  article-title: Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/awv288
– volume: 33
  start-page: 53
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib13
  article-title: A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/jcbfm.2012.131
– volume: 252
  start-page: 27
  year: 2005
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib29
  article-title: Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings
  publication-title: J. Neurol.
– volume: 262
  start-page: 1483
  year: 2015
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib30
  article-title: Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
  publication-title: J. Neurol.
– volume: 136
  start-page: 2228
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib15
  article-title: In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/awt145
– volume: 258
  start-page: 1841
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib7
  article-title: In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings
  publication-title: J. Neurol.
– volume: 10
  start-page: e0134956
  year: 2015
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib34
  article-title: A pilot study on clinical and neuroimaging characteristics of Chinese posterior cortical atrophy: comparison with typical Alzheimer's disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0134956
– volume: 134
  start-page: 2036
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib4
  article-title: Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/awr130
– volume: 46
  start-page: 1959
  year: 2005
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib17
  article-title: Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis
  publication-title: J. Nucl. Med.
– volume: 56
  start-page: 701
  year: 2015
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib18
  article-title: Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.114.146027
– volume: 84
  start-page: 1357
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib35
  article-title: Elevated occipital beta-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp-2013-305628
– volume: 25
  start-page: 1528
  year: 2005
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib27
  article-title: Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/sj.jcbfm.9600146
– volume: 63
  start-page: 1168
  year: 2004
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib31
  article-title: Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000140289.18472.15
– volume: 139
  start-page: 1551
  year: 2016
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib25
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/aww027
– volume: 37
  start-page: 849
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib22
  article-title: Tau oligomers and fibrils induce activation of microglial cells
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-131843
– volume: 131
  start-page: 665
  year: 2008
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib11
  article-title: 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
  publication-title: Brain
  doi: 10.1093/brain/awm336
– volume: 15
  start-page: 351
  year: 2008
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib32
  article-title: Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2008-15301
– volume: 257
  start-page: 469
  year: 2010
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib12
  article-title: Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex
  publication-title: J. Neurol.
– volume: 29
  start-page: 530
  year: 2010
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib2
  article-title: CSF-tau and CSF-Abeta(1-42) in posterior cortical atrophy
  publication-title: Dement Geriatr. Cogn. Disord.
  doi: 10.1159/000314679
– volume: 76
  start-page: 1006
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib10
  article-title: Classification of primary progressive aphasia and its variants
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821103e6
– volume: 126
  start-page: 479
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib19
  article-title: The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1177-7
– volume: 7
  start-page: 270
  year: 2011
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib1
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2011.03.008
– volume: 33
  start-page: 5053
  year: 2013
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib9
  article-title: Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4361-12.2013
– volume: 67
  start-page: 446
  year: 2006
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib21
  article-title: [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000228230.26044.a4
– volume: 44
  start-page: 53
  year: 2016
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib14
  article-title: 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2016.04.011
– volume: 64
  start-page: 1140
  year: 2007
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib24
  article-title: Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.64.8.1140
– volume: 32
  start-page: 1
  year: 2012
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib26
  article-title: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/jcbfm.2011.147
– volume: 32
  start-page: 412
  year: 2008
  ident: 10.1016/j.neurobiolaging.2016.12.006_bib5
  article-title: Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2008.08.001
SSID ssj0007476
Score 2.3878987
Snippet We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of...
Abstract We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a...
We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of...
We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa (TSPO), a marker...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 132
SubjectTerms Aged
Alzheimer Disease - diagnostic imaging
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer's disease
Amyloid - metabolism
Atrophy
Female
Glucose - metabolism
Humans
Internal Medicine
Male
Microglia - pathology
Middle Aged
Nerve Degeneration
Neuroinflammation
Neurology
Occipital Lobe - diagnostic imaging
Occipital Lobe - metabolism
Occipital Lobe - pathology
PET imaging
Positron-Emission Tomography
Protein Binding
Receptors, GABA - metabolism
Title Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0197458016303128
https://www.clinicalkey.es/playcontent/1-s2.0-S0197458016303128
https://dx.doi.org/10.1016/j.neurobiolaging.2016.12.006
https://www.ncbi.nlm.nih.gov/pubmed/28068564
https://www.proquest.com/docview/1857378555
https://pubmed.ncbi.nlm.nih.gov/PMC5381519
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VRUJcEFAey6MyEoJT2G5iO7YQQqtCtYDoBSr1ZjmOo6bqeleb7YEe-tuZcR6wtIcirk5Gtjzjmc_2zGeAVxNvpeOlTHwqfMJ1tZdo57NESK_zzAppC6od_nYoZ0f8y7E43oL9vhaG0io739_69Oitu5ZxN5vjZV2PvyM4yblADyvRDaObpQp2npOVv738neaBcFm2JdPE7632buP4hhyvyBlJbEfxRSBK9JLxcJDeP7o-TF2FoX9nU_4Rng7uwd0OV7JpO_T7sOXDA9iZBtxTz3-y1yxmesYj9B1YfaSFHdyaLSO7ZmjYomLYQAnqvmRril8U5HA_ziKRQx3wM1tSQciqxkbcssYzcEYn6agoZkPJ7DwQZYdj07OLE1_P_epNw7oLoIdwdPDpx_4s6d5eSJzQqUxSa50UlU1pv-cQZ1XCFZnkiovC0t2fxsnEtc11mSEEsGnqZJWVhZJcTGzFs0ewHRbBPwGmrC6kKrTm0nLlnULIlXupua28474awbt-qo3riMnpfYwz02egnZpNRRlSlJmkBhU1AjFIL1uCjhvKve-1avoiVHSbBiPJDeXz6-R90_mAxkxMg3-aK3Y6gg-D5Iap_0PfL3szNOgN6IrHBr84xz6VyLNcCSFG8Lg1y2FW6A4d557jyDcMdviBmMY3v4T6JDKOY1REZKif_vfIn8GdlHBRTOJ7Dtvr1bl_gahuXezGZbsLt6afv84OfwGpeFQB
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NTgJeEDAY5dNICJ6irontxEIIVYOpY1tf2KS9WY7jaEGrWzXdA_z13DkfomwPQ7w6Odm6O__ubJ9_Bng3dkZaXsjIxcJFXJV7kbIuiYR0Kk2MkCanu8MnMzk949_OxfkW7Hd3YaisssX-BtMDWrcto1abo2VVjb5jcpJygQgrEYYRZu_ANrFTiQFsTw6PprMekDFjls2taaL4zvbu4hD7Mq9AG0mER-FRIKr1kmF_kJ5AujlSXc9E_y6o_CNCHTyEB21qySbN6B_BlvOPYWficVk9_8nes1DsGXbRd2D1hea2t2u2DASbvmaLkmED1ai7gq0phFGcwyU5C1wOlcfPbEl3QlYVNuKqNWyDM9pMR1sx4wtm5p5YOyybXP66cNXcrT7UrD0DegJnB19P96dR-_xCZIWKZRQbY6UoTUxLPoupVilsnkiecZEbOv5TqEyc3lwVCWYBJo6tLJMizyQXY1Py5CkM_MK7Z8Ayo3KZ5UpxaXjmbIZZV-qk4qZ0lrtyCB87VWvbcpPTExmXuitC-6E3DaXJUHocazTUEEQvvWw4Om4p96mzqu7uoSJyagwmt5RPb5J3dQsDtR7rGv_U11x1CJ97yQ1v_4e-33ZuqBEQ6JTHeLe4wj4zkSZpJoQYwm7jlr1W6Bgddc9x5BsO2_9AZOObX3x1EUjHMTBicqie__fI38C96enJsT4-nB29gPsxpUmhpu8lDNarK_cKk7x1_rqdxL8BEv9Wsg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distinct+patterns+of+increased+translocator+protein+in+posterior+cortical+atrophy+and+amnestic+Alzheimer%E2%80%99s+disease&rft.jtitle=Neurobiology+of+aging&rft.au=Kreisl%2C+William+C.&rft.au=Lyoo%2C+Chul+Hyoung&rft.au=Liow%2C+Jeih-San&rft.au=Snow%2C+Joseph&rft.date=2017-03-01&rft.issn=0197-4580&rft.eissn=1558-1497&rft.volume=51&rft.spage=132&rft.epage=140&rft_id=info:doi/10.1016%2Fj.neurobiolaging.2016.12.006&rft_id=info%3Apmid%2F28068564&rft.externalDocID=PMC5381519
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01974580%2FS0197458016X00140%2Fcov150h.gif